MC Endeavors, Inc. Files Termination of Reg A
CEO Steven Mazurek has filed Termination Documents with the SEC for the Reg A
ALISO VIEJO, CA, Dec. 19, 2019 (GLOBE NEWSWIRE) -- MC Endeavors, Inc. /CBD Liquid Labs (PINKSHEETS: MSMY) Mr. Mazurek has followed through and terminated the Reg A which had 95 million shares remaining out of the 300 million shares that were registered.
Mr. Mazurek stated, “Management is fully committed to building shareholder value by increasing revenues and maintaining margins through a financially responsible and disciplined set of business practices. We are aware of the persistent selling pressure we have been experiencing in the public market and we are investigating where it is coming from and why it has continued. Being transparent to the shareholders and the market, the company did raise approximately $360,000 with the Reg A and has not issued any stock since early November. 25 million shares were issued to GPL on November 5th, and before that, 45 million shares to Continuation Capital on Sept 5th.”
Mr. Mazurek further stated, “the company plans to up list to the OTC:QB next year once the audited financials are completed, with no plans to Reverse Split the stock.”
About Eclipse Liquids/CBD Liquid Labs
Founded in 2013, Eclipse Liquids is one of only 34 AEMSA certified and FDA registered clean room laboratories and production facilities for eLiquid private label manufacturing in the country. Through years of honing our manufacturing processes, developing and innovating new products and building a loyal and dedicated staff, Eclipse has grown to become a leader in the CBD Product manufacturing industry. Specializing in private label premium CBD products serving the needs of small-scale businesses to large multi-national companies.
The Company offers a broad range of capabilities, from custom recipe development with full production and manufacturing, to confidential private labeling of your branded CBD products.
Video Tour of Eclipse Liquids see-
Additional Facility Pics -
Safe Harbor Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE MC Endeavors, Inc
For further information contact:
Steven Mazurek
CEO
MC Endeavors, Eclipse Liquids
Phone: (949)448-0074
E-mail:
